Roche Primary Care Partnerships Likely; Focus Shifting To Specialty Products

Insulin sensitizer, dual-acting integrin antagonist for asthma are among possible partnering opportunities. Roche's next primary care launch, the osteoporosis agent Boniva, will be co-marketed with GlaxoSmithKline.